Douglas Dawson, MD
Otolaryngology · Green Bay, WINPI 1275519043
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 55.0% of the total. Reporting peaked in 2023 at $1,012 and has fallen 92.9% since, to $71 in 2025.
Across 27 payments — averaging $85.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Stryker$612
- GSK$138
- AstraZeneca$84
- Regeneron Healthcare Solutions, Inc.$72
- Medtronic$49
- plus $82 from 2 others
What the payments were for
- Travel & lodging$1,29556%
- Food & beverage$1,00844%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 17 | $1,267 |
| Stryker | 2 | $612 |
| GSK | 2 | $138 |
| AstraZeneca | 1 | $84 |
| Regeneron Healthcare Solutions, Inc. | 1 | $72 |
| Medtronic | 1 | $49 |
| Acclarent, Inc | 1 | $43 |
| Intersect ENT, Inc. | 2 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,303 in reported general payments places this provider in the 80th percentile of 168 otolaryngology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $44,330 |
| Ipratropium Bromide | 17 | $796 |
| Fluticasone Propionate | 51 | $382 |
| Ciprofloxacin Hcl | 20 | $284 |
| Chlorhexidine Gluconate | 15 | $63 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Green Bay
- Michael OldenburgGreen Bay$8K
- Jon SlezakGreen Bay$3K
- Robert SonnenburgGreen Bay$3K
- Sarah TittmanGreen Bay$1K
- Scott HuntGreen Bay$955
- Jason BrantMadison$103K
- B WoodsonMilwaukee$45K
- Thomas Gessertla Crosse$21K
- Colleen PleinKenosha$16K
- Steven SperryGreenfield$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.